State Development & Investment Corporation (SDIC)

Total investments

29

Average round size

155M

Portfolio companies

28

Rounds per year

1.00

Lead investments

6

Follow on index

0.03

Exits

4

Areas of investment
AutomotiveBiotechnologyInformation TechnologyHealth CareManufacturingMedicalIntelligent SystemsPharmaceuticalIndustrialBiopharma

Summary

State Development & Investment Corporation (SDIC) appeared to be the VC, which was created in 1995. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Beijing.

The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. This State Development & Investment Corporation (SDIC) works on 4 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 42 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 50 - 100 millions dollars. The increased amount of exits for fund were in 2018.

Among the most popular fund investment industries, there are Medical, Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Innovent Biologics, Video++, Realmax. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - China.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the State Development & Investment Corporation (SDIC), startups are often financed by F-Prime Capital, Lilly Asia Ventures, Eight Roads Ventures. The meaningful sponsors for the fund in investment in the same round are YuanMing Capital, YF Capital (Yunfeng Capital), Toutoushidao Capital. In the next rounds fund is usually obtained by YuanMing Capital, Wenxuan Equity Investment Fund, UBTech Robotics.

Show more

Investments analytics

Analytics

Total investments
29
Lead investments
6
Exits
4
Rounds per year
1.00
Follow on index
0.03
Investments by industry
  • Biotechnology (8)
  • Pharmaceutical (8)
  • Manufacturing (8)
  • Medical (7)
  • Automotive (5)
  • Show 38 more
Investments by region
  • China (29)
Peak activity year
2021
Number of Unicorns
4
Number of Decacorns
4
Number of Minotaurs
3

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Avg. valuation at time of investment
496M
Group Appearance index
0.72
Strategy success index
0.80

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Lithotripsy of Northern Indiana 06 Apr 2022 Biotechnology, Fitness, Health Care Seed 206K United States, Texas, Austin
Ollie Gray 01 Aug 2020 Fashion, Shoes Early Stage Venture 71K United States, North Carolina, Charlotte
Realmax 01 May 2017 Information Technology, Augmented Reality Early Stage Venture 30M Shanghai, China
Seamless Vision 20 Dec 2020 Logistics, Software, Information Technology, Artificial Intelligence, Machine Learning, Hospital, Geospatial, Sensor Seed 3M Tel Aviv, Tel Aviv, Israel
Zhongke Fuhai 03 Aug 2023 Manufacturing, Energy Late Stage Venture 123M Beijing, Haidian, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.